Filspari Drug Interactions: 103 Major, 411 Moderate
Filspari (Sparsentan) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Filspari. Always confirm against the full prescribing information.
100 interactions
Abrocitinib
The serum concentration of Abrocitinib can be decreased when it is combined with Sparsentan.
Level 1 evidence
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Sparsentan.
Level 1 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be decreased when it is combined with Sparsentan.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Sparsentan.
Level 1 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Sparsentan.
Level 2 evidence
Aficamten
The serum concentration of Aficamten can be decreased when it is combined with Sparsentan.
Level 1 evidence
Albendazole
The serum concentration of Albendazole can be decreased when it is combined with Sparsentan.
Level 1 evidence
Allopurinol
Sparsentan may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Level 2 evidence
Almasilate
The therapeutic efficacy of Sparsentan can be decreased when used in combination with Almasilate.
Level 1 evidence
Alosetron
The serum concentration of Alosetron can be decreased when it is combined with Sparsentan.
Level 1 evidence
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Sparsentan.
Level 1 evidence
Aluminium phosphate
The therapeutic efficacy of Sparsentan can be decreased when used in combination with Aluminium phosphate.
Level 1 evidence
Enter your NPI to unlock 24 major interactions for Filspari
Filspari (Sparsentan) has 535 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Filspari (Sparsentan) has 103 major, 411 moderate, and 21 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Filspari. Always confirm against the full prescribing information.